Phase 3 Netherton Syndrome Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Netherton Syndrome
Quoin Pharmaceuticals16 enrolled5 locationsNCT07538583
Recruiting
Phase 2Phase 3
Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Netherton Syndrome
Quoin Pharmaceuticals8 enrolled1 locationNCT06953466
Recruiting
Phase 2Phase 3
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
Netherton Syndrome
Quoin Pharmaceuticals20 enrolled4 locationsNCT05789056